GANIRELIX Drug Patent Profile
✉ Email this page to a colleague
When do Ganirelix patents expire, and when can generic versions of Ganirelix launch?
Ganirelix is a drug marketed by Amphastar Pharms Inc, Gland, Lupin, Meitheal, Organon Usa Organon, Qilu, and Tris Pharma Inc. and is included in seven NDAs.
The generic ingredient in GANIRELIX is ganirelix acetate. There are four drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the ganirelix acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ganirelix
A generic version of GANIRELIX was approved as ganirelix acetate by ORGANON USA ORGANON on July 29th, 1999.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for GANIRELIX?
- What are the global sales for GANIRELIX?
- What is Average Wholesale Price for GANIRELIX?
Summary for GANIRELIX
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 7 |
| Drug Prices: | Drug price information for GANIRELIX |
| DailyMed Link: | GANIRELIX at DailyMed |
US Patents and Regulatory Information for GANIRELIX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphastar Pharms Inc | GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 212613-001 | Apr 7, 2022 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Tris Pharma Inc | GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 219454-001 | Jun 27, 2025 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Meitheal | GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 214996-001 | Jun 6, 2022 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Gland | GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 215658-001 | Feb 28, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Lupin | GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 216075-001 | Nov 16, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Qilu | GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 218855-001 | Apr 23, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
